Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuroscience Letters

• Publication date

  1998-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0304-3940(97)00919-1PMID 9488168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional evidence for PCP-like effects of the anti-stroke candidate MK-801

  2005cited by this paper
• Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

  2005cited by this paper
• Medical therapy for ischemic stroke.

  1996cited by this paper
• Strategies for Neuroprotection with Glutamate Antagonists

  1995cited by this paper
• Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.

  1995cited by this paper
• Safety, Tolerability and Pharmacokinetics of the N‐Methyl‐d‐Aspartate Antagonist Ro‐01–6794/706 in Patients with Acute Ischemic Stroke a b

  1995cited by this paper
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cited by this paper
• Basic aspects of epilepsy.

  1993cited by this paper
• The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy.

  1993cited by this paper
• The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report.

  1992cited by this paper
• The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.

  1992cited by this paper
• Autoradiographic analysis of 3H-MK-801 (dizocilpine) in vivo uptake and in vitro binding after focal cerebral ischemia in the rat.

  1992cited by this paper
• Neurocytotoxicity: pharmacological implications

  1991cited by this paper
• Responses to NMDA receptor antagonists altered by epileptogenesis.

  1991cited by this paper
• Brain edema and cerebrovascular permeability during cerebral ischemia in rats.

  1990cited by this paper
• A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.

  1986cited by this paper

• Neurotoxicity and Stroke

  2014cites this paper
• Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.

  2014cites this paper
• Anestésicos, Pre-condicionamiento y Protección Cerebral

  2013cites this paper
• Anesthetics, cerebral protection and preconditioning.

  2013cites this paper
• Anesthetics, cerebral protection and preconditioning.

  2013cites this paper
• In Vitro Evaluation of Guanidine Analogs as Sigma Receptor Ligands for Potential Anti-Stroke Therapeutics

  2013cites this paper
• Synthesis and pharmacological evaluation of 3-amino-1-(5-indanyloxy)-2-propanol derivatives as potent sodium channel blockers for the treatment of stroke.

  2012cites this paper
• Aus dem Lehrstuhl für Pharmakologie, Toxikologie und Pharmazie des Veterinärwissenschaftlichen Departments der Tierärztlichen

  2010cites this paper
• Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.

  2010cites this paper
• GLUTATIONA EM CAMUNDONGOS

  2005cites this paper
• Anaesthesia induced neuroprotection.

  2005cites this paper
• Epilepsy (Ionotropic Glutamate Receptors as Therapeutic Targets)

  2002cites this paper
• Effect of graded hypoxia on the high-affinity CPP binding site of the NMDA receptor in the cerebral cortex of newborn piglets.

  2001cites this paper
• A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke.

  2001cites this paper
• AR-R15896AR, a low affinity, use-dependent, NMDA antagonist, is protective in a primate model of stroke ☆ ☆☆

  2000cites this paper
• Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.

  2000cites this paper
• Glutamate receptor ion channels : Activators and inhibitors

  2000cites this paper
• Novel targets for therapeutic intervention against ischemic brain injury.

  1999cites this paper
• Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.

  1999cites this paper
• Ischemic cell death in brain neurons.

  1999cites this paper
• Monotherapy with dextromethorphan or tirilazad – but not a combination of both – improves outcome after transient focal cerebral ischemia in rats

  1998cites this paper